(781) 222-1022 | [email protected]

Blog

Insights and updates from Safety Partners

Blog

Insights and updates from Safety Partners

The use of fresh blood drawn from company employees is sometimes required when timelines in experiments are too tight to use an outside blood supply vendor. That said, it is considered to be preferable from a safety standpoint, and often a logistical one as well, that an outside blood supply vendor be used rather than establishing an in-house program.
Many of Safety Partners’ clients hold Controlled Substances Registrations (Researcher) for the research use of controlled substances.  In Massachusetts, a controlled substance includes all drugs regulated by the Drug Enforcement Agency (DEA) in schedules I through V as well as Schedule VI, which is defined as all prescription drugs, which are not included in any other schedule. 
After six years of sharing safety tips, we are excited to add more Safety Partners experts to our blog team.  Starting next week, our Quality, Research, and Training (QRT) team members will contribute to our weekly posts.
Today will be my last post to the Safety Partners blog as I transition into a new phase!  I want to thank you for taking time out of your busy schedule to read our blog, and I hope that I have been able to share some valuable information to support your EH&S program. 
OSHA’s Bloodborne Pathogen Standard, 29 CFR 1910.1030, applies to all occupational exposure to human blood or other potentially infectious material as defined in the standard.  When implementing a bloodborne pathogen program, the standard needs to be reviewed in detail to ensure full compliance is achieved.